Pacific Biosciences of California, Inc. (PACB)
NASDAQ · Healthcare
Pacific Biosciences of California, Inc. Shareholder Equity 2009–2025
Pacific Biosciences of California, Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Pacific Biosciences of California, Inc. shareholder equity as of December 31, 2025: 5.3M, a 98.94% decrease year-over-year.
- Pacific Biosciences of California, Inc. shareholder equity for 2025 were 5.3M, a 98.94% decrease from 2024.
- Pacific Biosciences of California, Inc. shareholder equity for 2024 were 506.6M, a 27.76% decrease from 2023.
- Pacific Biosciences of California, Inc. shareholder equity for 2023 were 701.3M, a 24.59% increase from 2022.
- Pacific Biosciences of California, Inc. shareholder equity for 2022 were 562.9M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Pacific Biosciences of California, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $5 |
| 2024 | $507 |
| 2023 | $701 |
| 2022 | $563 |
| 2021 | $791 |
| 2020 | $335 |
| 2019 | $55 |
| 2018 | $114 |
| 2017 | $86 |
| 2016 | $85 |
| 2015 | $74 |
| 2014 | $55 |
| 2013 | $69 |
| 2012 | $109 |
| 2011 | $191 |
Pacific Biosciences of California, Inc. Shareholder Equity — FAQ
Pacific Biosciences of California, Inc. (PACB) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PACB's shareholder equity history?
The chart and table above show Pacific Biosciences of California, Inc.'s shareholder equity by year and by quarter, including the growth rate.